Lovastatin Tablet
Product Images NDC 50090-0757

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 50090-0757). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500900757)

This appears to be a product label or packaging information for a package of Lovastatin, which appears to contain 30 tablets and has a product number of 5345-0. The dosage strength of the Lovastatin tablets is not clearly indicated from the given text.*

FDA Label Image

Structural Formula (Lov00 0004 01)

FDA Label Image

Table I (Lov00 0004 02)

FDA Label Image

Figure 1 (Lov00 0004 03)

This is a figure labeled "Proportion of Participants Without Event" displaying the percentage of individuals who did not experience an acute major coronary event (primary endpoint) over the course of 4 years of follow-up. No further information is available.*

FDA Label Image

Table Vii (Lov00 0005 04)

This is a table outlining drug interactions that could potentially increase the risk of myopathy/rhabdomyolysis. The table provides prescribing recommendations for different drugs including strong CYP3A4 inhibitors, HIV protease inhibitors, gemfibrozil, cyclosporine, danazol, diltiazem, and dronedarone. The table contains dosing instructions and contraindications for each medication. It also advises avoiding grapefruit juice.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.